Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.


TSXV:APC.H - Post by User

Post by Goldnboy1on Oct 04, 2021 2:08am
215 Views
Post# 33959650

Covid Therapy

Covid Therapy

New presentation on website suggests company is pursuing the development of a drug that competes or exceeds the abilities of Remdesevir.

Stated pretty clearly in the presentation. Here is the link. 

Six compound families rationally designed. Sounds like the company has isolated six opportunities in silico. Better than having just one shot at it! We have six shots at it!

Expecting the company to move rapidly into in vivo/in vitro animal studies once compounds fully synthesized.

Also hearing the company and the NIH have been in touch. Would be amazing to get some non dilutive funding. Remember the company is technically American based but Canadian majority owned  

Stock touching long term moving average could see a solid turn from here this week. I'm hearing news floodgate about to burst soon.

https://www.advancedproteome.com/wp-content/uploads/2021/09/SARS-CoV-2-Mpro.pdf

<< Previous
Bullboard Posts
Next >>